![](data:image/svg+xml,<svg display="block" id="187485351" role="presentation" viewBox="0 0 21 17" xmlns="http://www.w3.org/2000/svg"><path d="M 0 0 L 19 0" fill="transparent" height="1px" id="fAwrX31Ho" stroke-dasharray="0" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" stroke="rgba(22, 30, 40, 0.9)" transform="translate(1 3)" width="19px"/><path d="M 0 0 L 19 0" fill="transparent" height="1px" id="BpzY28YkB" stroke-dasharray="0" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" stroke="rgba(22, 30, 40, 0.9)" transform="translate(1 8.72)" width="19px"/><path d="M 0 0 L 19 0" fill="transparent" height="1px" id="IBoyu11e2" stroke-dasharray="0" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" stroke="rgba(22, 30, 40, 0.9)" transform="translate(1 14)" width="19px"/></svg>)
Pioneers in Speech Biomarkers
Accelerate Clinical Trials with AI-driven Speech Biomarkers
Reduce screen failures by up to 35%, lower patient burden, and unlock objective, remote measures across neurodegenerative and neuropsychiatric portfolios.
Trusted by leading pharma sponsors and research institutions
Pioneers in Speech Biomarkers
Accelerate Clinical Trials with AI-driven Speech Biomarkers
Reduce screen failures by up to 35%, lower patient burden, and unlock objective, remote measures across neurodegenerative and neuropsychiatric portfolios.
Trusted by leading pharma sponsors and research institutions
Pioneers in Speech Biomarkers
Accelerate Clinical Trials with AI-driven Speech Biomarkers
Reduce screen failures by up to 35%, lower patient burden, and unlock objective, remote measures across neurodegenerative and neuropsychiatric portfolios.
Trusted by leading pharma sponsors and research institutions
De-Risk
Your Protocol
Optimize every phase of your study lifecycle, from high-precision remote pre-screening to continuous longitudinal tracking.
01
Protocol Design
Based on your study goals and needs, we work with you to define appropriate speech tasks and endpoints.
02
Collection
Participants complete a short spoken task via any telephone, smartphone app, or web browser.
03
Automated Analytics
Our AI pipeline returns objective biomarker scores to your Data Management Plans.
Choose Your Therapeutic Area
Select a category below for targeted evidence, validation data, and resources.
NEURODEGENERATION
Alzheimer's Disease
MOVEMENT DISORDERS
ALS/MND · Parkinsonian Syndromes
PSYCHIATRy
Depression (MDD) · Schizophrenia
A ~9-minute phone call to streamline participant pipelines
The Speech-based Biomarker for Cognition (SB-C) captures memory, processing speed, and executive function domains through a standardized set of spoken tasks — optimizing cognitive assessments. An automated, objective cognitive score is returned (no clinician, no specialized hardware needed) to accelerate recruitment.
Explore Alzheimer's
![](data:image/svg+xml,<svg display="block" id="3801109173" role="presentation" viewBox="0 0 40 40" xmlns="http://www.w3.org/2000/svg"><path d="M 20 40 C 8.954 40 0 31.046 0 20 L 0 20 C 0 8.954 8.954 0 20 0 L 20 0 C 31.046 0 40 8.954 40 20 L 40 20 C 40 31.046 31.046 40 20 40 Z" fill="rgba(57, 161, 255, 0.3)" height="40px" id="EFcKS_yAG" width="40px"/><path d="M 9.432 16.2 L 7.779 14.655 L 13.518 9.229 L 0 9.229 L 0 6.971 L 13.518 6.971 L 7.779 1.554 L 9.432 0 L 18 8.1 Z" fill="rgb(57, 161, 255)" height="16.2px" id="yjpG7Q3z8" transform="translate(11 11.86)" width="18px"/></svg>)
Choose Your Therapeutic Area
Select a category below for targeted evidence, validation data, and resources.
NEURODEGENERATION
Alzheimer's Disease
MOVEMENT DISORDERS
ALS/MND · Parkinsonian Syndromes
PSYCHIATRy
Depression (MDD) · Schizophrenia
Choose Your Therapeutic Area
Select a category below for targeted evidence, validation data, and resources.
NEURODEGENERATION
Alzheimer's Disease
MOVEMENT DISORDERS
ALS/MND · Parkinsonian Syndromes
PSYCHIATRy
Depression (MDD) · Schizophrenia
A ~9-minute phone call to streamline participant pipelines
The Speech-based Biomarker for Cognition (SB-C) captures memory, processing speed, and executive function domains through a standardized set of spoken tasks — optimizing cognitive assessments. An automated, objective cognitive score is returned (no clinician, no specialized hardware needed) to accelerate recruitment.
Explore Alzheimer's
© ki:elements GmbH 2026 · Saarbrücken, Germany
© ki:elements GmbH 2026 · Saarbrücken, Germany
© ki:elements GmbH 2026 · Saarbrücken, Germany